Immunology of Diabetes Society

✨ That's a Wrap on #IDS2024 in Beautiful Bruges! ✨ As we close out the IDS2024 conference, we want to extend our heartfelt thanks to everyone who joined us! This year, we welcomed 500 attendees from 30 countries, creating an inspiring mix of global perspectives, groundbreaking research, and meaningful discussions.🌍 From the bustling poster sessions and insightful presentations to the special moments shared over local delicacies like Bruges cheese and Brugse Zot, each of you contributed to making this event truly unforgettable. A huge thank you to our speakers, sponsors, volunteers, the organizing committee and especially the participants, for bringing such energy, curiosity, and collaboration to every corner of the event. We’re already looking forward to seeing where these conversations lead in the next IDS congress. See you in Brisbane, Australia, in 2026! KU Leuven Congresbureau - PCO, CONCERTGEBOUW BRUGGE, Stad Brugge, chantal mathieu, Carmella Evans-Molina, Conny Gysemans, Lut Overbergh, Decio Eizirik, Roberto Mallone, Sylvaine You, Doryssa Hermans

IDS Congress Day 5: Closing a Transformative Week As we reach the final day of the 20th IDS Congress, attendees can look forward to a compelling program that brings together the week’s insights and looks ahead to the future of T1D research. The day opens with Plenary 5, where Jeffrey Bluestone, a pioneer in immunology and co-founder of teplizumab, will delve into the role of regulatory T cells (Tregs) in T1D. Bluestone’s groundbreaking work on immune tolerance and T cell modulation has been instrumental in developing therapies that preserve beta cell function, including the landmark teplizumab, which has reshaped how we think about delaying T1D onset. Following this, Session 12 will explore unconventional contributors to T1D, with presentations on everything from tissue transcriptional signatures to innovative macrophage reprogramming strategies. These sessions promise to introduce new approaches that challenge traditional perspectives on T1D pathogenesis and treatment. A highlight of the day is the Roundtable: To Screen or Not to Screen?, where top experts like Simon Griffin, Anette Ziegler, and Kristine Bell will engage in a lively discussion on the complexities and potential of T1D screening. This discussion will provide attendees with diverse perspectives on early diagnosis and the path toward preventive care. The Congress will then wrap up with Take-Home Messages, where key speakers summarize the insights and breakthroughs from a week rich in scientific discovery. Concluding remarks from Chantal Mathieu will offer a final reflection on the week’s achievements and inspire us to carry forward the ideas sparked in Bruges. As we close the IDS Congress 2024, we thank all attendees and contributors for a successful week and look forward to future progress in T1D research. Safe travels to all, and see you at the next IDS!

Excited to be here at the Immunology of Diabetes Society #IDS2024 Congress in Bruges! The welcome pack is fantastic – so thoughtful and well-prepared with Hippo the mascot and the umbrella that I already used ☔. Thanks to chantal mathieu and the local organizing team for an amazing meeting and giving us the opportunity to present our work on Friday morning in session 12, Not the usual suspects in #T1D. Don't miss out💪💯

💙 Have You Spotted Hippo at #IDS2024? 💙 This year, each IDS2024 goodie bag includes a special guest: a little hippo keychain, the beloved mascot from Hippo & Friends type 1 diabetesfonds! 🦛 Hippo has become a symbol of support, courage, and community for Belgian children affected by #type1diabetes. Founded by the vzw Hippo and Friends, Hippo was created to bring awareness and offer comfort to children and families living with type 1 diabetes. Hippo sounds like 'hypo', referring to hypoglycemia. With every keychain, we carry a piece of that support with us. 💙 Take a look around—Hippo has made its way to #IDS2024! Have you spotted one yet? Share your photos and help spread the word about this wonderful initiative! 📸 More information: https://lnkd.in/eSBu36U8 #IDS2024 #hippoandfriend #Type1DiabetesAwareness #Community #Support

Day 4 at the IDS Congress has kicked off, packed with insightful sessions on cutting-edge tech and innovative approaches in T1D research! Today’s lineup includes sessions on novel modeling techniques, beta-cell targeting therapies, and the much-anticipated debate on T cell biomarkers in peripheral blood. 💥 Feeling the energy from last night’s Dinner & Dance? If you survived the dance floor, we’ll see you at Plenary 4; no guarantees on everyone’s voices making it after all that singing! 🎶 Stay tuned, stay engaged, and let’s keep the momentum going! #IDS2024

Prof Tom Kay paying tribune to the late Prof Helen Thomas at #IDS2024 we remember our colleague with respect and love Breakthrough T1D JDRF Australia

✨ Highlights from Last Night’s #IDS2024 Poster Session! ✨ What an inspiring evening we had at the IDS2024 poster session! The energy was incredible as professionals from around the globe gathered to discuss the latest innovations and insights in our field. With each poster came new ideas, diverse perspectives, and fruitful discussions that sparked curiosity and collaboration.💡 As we delved into these conversations, guests were treated with local specialties, including the famous Bruges’ cheeses, paired with delicious wines. 🧀 Thank you to everyone who presented, shared ideas, and made it such a memorable night! We are already looking forward to poster session 2 on Thursday!

#IDS2024 - Wednesday Highlights 📍 Today at the IDS Congress, we dive into cutting-edge insights in T1D research, starting with a plenary on T-cell engineering by Jane Buckner. Look out for the “Rising Stars” session where promising early-career researchers share their work on T1D progression, autoantibodies, and microRNAs. At lunchtime, Dexcom hosts an industry symposium covering new developments in sensor technology and the InRange study results. Afternoon sessions include a T-cell workshop and hot oral abstracts. The day wraps up with insights on early life’s impact on T1D development, leading into tonight’s much-anticipated IDS Dinner & Dance at Brewery De Halve Maan!

✨ Sneak Peek into IDS2024 VIP Welcome Reception in Bruges! ✨ Last night, we kicked off #IDS2024 with an unforgettable VIP welcome reception at the stunning city hall in Stad Brugge – a venue that truly embodies the charm and history of this medieval city. Guests were treated not only to the elegance of the 14th-century hall but also to the unique taste of Brugse Zot, Bruges' very own beer. 🍻 For those unfamiliar, Brugse Zot is more than just a drink; it's a celebration of local tradition and craftsmanship. Brewed by the Brouwerij De Halve Maan, a family-run establishment dating back to 1856, Brugse Zot is the only beer still brewed within the walls of Bruges. The name, which translates to "Bruges Fool," harks back to local folklore, where the people of Bruges are affectionately known as “Zotten” or “fools."

Day 2 at #IDS2024 is packed with groundbreaking insights! 🌟 🔬 Kickstart with the Eisenbarth Lecture by Carla Greenbaum on immune pathways in T1D. 🩺 Don’t miss: Quick-fire session on the latest T1D clinical trials, including advances in therapies like Ustekinumab and Teplizumab. 💉 Is islet transplantation ready? Dive deep with experts Jason Gaglia & Lorenzo Piemonti on this transformative topic. 🎤 Debate: Antigen-specific therapy — innovative potential or not worth the effort? And join us in the evening for Poster Session I to explore pioneering research up close! Stay tuned for real-time updates.